Obesity is a complex, chronic disease, affecting over 1 billion people worldwide
Obesity is influenced by a combination of genetic, environmental, and behavioural factors. Recognition and understanding these factors is an important aspect of helping your patients manage their weight, some of which are outside your patients control.1
Obesity is typically assessed using the Body Mass Index (BMI) calculation. Additional assessments may include evaluating waist circumference, body composition, and assessing obesity-related comorbidities. Medical history-taking and physical examination also help to identify potential underlying causes and associated risk factors.
Managing the care for your patient with obesity involves a patient-centred approach. Personalised treatment plans, incorporating lifestyle modifications, such as dietary changes, increased physical activity, and behavioural interventions should focus on helping the patient achieve the best weight that they can sustain over time.2 In some cases, pharmacotherapy and bariatric surgery may be considered.
It is important for Health care professionals to recognise the impact of emotional factors, such as stress, self-esteem, body image, and social stigma, and provide support and resources (or refer to other appropriate health care professionals) for managing these challenges.
Consilient Health provide a range of educational webinars on various topics including obesity. If you wish to register for our webinars or view previous webinar recordings, please click here.
References
- 9 reasons why obesity is not a choice. https://www.healthline.com/nutrition/9-reasons-obesity-is-not-a-choice.
- https://www.mybestweight.ie/mybestweight.
▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions
IE-MYS-215(1), MYS-0454-001 01/26 DOP: January 2026
The information on this website is intended for Healthcare Professionals who reside in Ireland and Malta only.
Healthcare professionals who reside in Ireland are asked to report any suspected adverse events to: HPRA Pharmacovigilance via www.hpra.ie;
Adverse events should also be reported to Orexigen: +353 1800 849 099 or Currax.Ml@primevigilance.com.
Healthcare professionals who reside in Malta are asked to report any suspected adverse events to: the Malta Medicines Authority via http://medicinesauthority.gov.mt/adrportal or Vivian Corporation Ltd. via pv@viviancorp.com.
Adverse events should also be reported to Orexigen: +356 800 62176 or Currax.Ml@primevigilance.com.